Pharmaceutical Environmental Risk Assessment

Home→ERA Profiles → Pentoxyverine→

Pentoxyverine Environmental Risk Assessment (ERA) report

Project-specific environmental risk assessment (ERA) support for human medicinal products and regulatory submissions.

CAS Registry Number
77-23-6
Molecular formula
C20H31NO3
Molecular weight
333.5 g/mol
Drug class
Non-opioid antitussivecentrally acting cough suppressant
Mechanism of action
Suppresses cough reflex activity, with predominant central nervous system actions proposed. The precise molecular mechanism is not fully established; sigma, opioid-related and antimuscarinic effects have been investigated.
Indications / reported uses
  • Symptomatic relief of non-productive (dry) cough associated with common cold, influenza, bronchitis or sinusitis, where the product is authorised.

Sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11060423/ · FDA product information

View request basketPrefer email? info@toxwriter.com
Phase IPhase II where requiredEU / UK / other markets
Assessment scope

Environmental Risk Assessment (ERA)

ToxWriter provides project-specific support for the Pentoxyverine Environmental Risk Assessment (ERA) (the Pentoxyverine ERA report). The required pathway is determined by the medicinal product, active-substance form, route, intended market, use assumptions and available environmental evidence.

Assessment may cover

  • Product, active-substance identity, formulation, route and intended-market review.
  • Phase I environmental exposure screening and applicable trigger evaluation.
  • Phase II environmental fate and ecotoxicity assessment where required by the applicable pathway.
  • PEC/PNEC risk characterisation and PBT/vPvB considerations where relevant and supported by evidence.
  • Data-gap analysis, study strategy, assumptions and scientific reporting.
ERA regulatory framework

The EMA guideline sets out the EU framework for environmental risk assessment of human medicinal products. MHRA guidance describes UK expectations; the applicable scope depends on the product and submission context.